USP9X deubiquitinates Ub-SNCA

Stable Identifier
R-HSA-5660752
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
USP9X deubiquitinates Ub-SNCA
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The deubiquitinase USP9X binds and deubiquitinates alpha-synuclein (SNCA) in vitro and in vivo, showing co-accumulation with SNCA in Lewy Bodies. Knockdown of USP9X expression in conditions of proteolytic inhibition leads to the accumulation of monoubiquitinated SNCA and increases the aggregation of SNCA into toxic inclusions, strengthening the connection between monoubiquitination, inclusion formation, and toxicity of SNCA. USP9X cytosolic levels are lower in Diffuse Lewy Body disease and Parkinson's Disease tissues, which may contribute to the accumulation and aggregation of monoubiquitinated SNCA (Rott et al. 2011).
Literature References
PubMed ID Title Journal Year
22065755 ?-Synuclein fate is determined by USP9X-regulated monoubiquitination

Rott, R, Szargel, R, Haskin, J, Bandopadhyay, R, Lees, AJ, Shani, V, Engelender, S

Proc. Natl. Acad. Sci. U.S.A. 2011
Participants
Input
Output
Participates
as an event of
Catalyst Activity

cysteine-type peptidase activity of USP9X:Ub-SNCA [cytosol]

Physical Entity
USP9X:Ub-SNCA [cytosol] (Homo sapiens)
Activity
cysteine-type peptidase activity (GO:0008234)
Authored
Jupe, S  (2015-01-06)
Reviewed
Perry, G  (2015-11-09)
Created
Jupe, S  (2015-01-06)
Cite Us!